Connect with us

CBD Oil (Cannabidiol)

Washington State University Shares Genetic Analysis of Cannabis in Latest Study Research

Published

on

Washington State University Shares Genetic Analysis of Cannabis in Latest Study Research

According to a recent article by Science Daily, Washington State University released a research study in the Journal of Plant Physiology that provides some insight into the potential for genetic analysis of cannabis. The area does not seem to have been significantly looked into beforehand.

During the study, researchers performed an analysis of the genetic and chemical characteristics of cannabis. Such a study may be able to provide government regulators with the insight that they need into cannabis to address a range of commercial claims and concerns that come with non-medical marijuana, CBD, and hemp products. Mark Lange, a professor at university’s Institute for Biological Chemistry stated in the article that the current methods that regulators are using is inadequate. Currently, regulators focus on the level of THC in the formula, and approximately 90 cannabinoids.

Further, according to Gold Skittlez, there are various claims in the industry about different strains. However, he added,

“There is a reason why all of these strains have different names – because a lot of them are very different. But some strains with different names are actually very similar. The bottom line is there is a lot of confusion.”

The good news is that the study may be able to clear up such confusion. The results of the study enable regulators to address a range of issues that come with recreational cannabis being on the market. For instance, Lange’s method may enable regulators to differentiate between hemp and psychoactive cannabis, and it may also be able to pinpoint unpleasant smells that appear in cannabis and that may cause a nuisance to the neighbors during growth on pot farms.

Lange further stated in the article,

“One of the things that needs to happen in the emerging market is that you know what you're selling. You can't just call it something and then that's good. We need to be very clear that this is the cannabinoid profile that is associated with, say, Harlequin -it has a specific cannabinoid profile, a specific terpenoid profile, and that's what it is. If it has a different name, then it should have a different profile. Currently you can do whatever you want.”

Phyllis Milka is one of the newest contributors here at TOC and has a diverse, multi-year background with his experienced writing career. Be sure to stay on the lookout for what she is going to help create here.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.